Emerging Healthcare: Key inflection points in an uncertain world

Investing in small/micro-cap healthcare is challenging due to a lengthy and binary driven product cycle, which is punctuated with bouts of excessive share volatility. While a pure momentum strategy that rides on investor enthusiasm, knowledge of the timing and share impact of different catalysts (eg regulatory events, clinical trial readouts, commercial milestones, etc) creates an opportunity for investors to benefit from volatility around high-impact events. In this note, we highlight key catalysts expected before calendar year end across the emerging healthcare sector. Report attached


1 topic

Scott Power
Senior Analyst
Morgans

Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...

Expertise

No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.